drugset / Trial / NCT01237522

A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers

NCT01237522 ↗

Phase 4 Completed 50 enrolled University of Southern Denmark
Non-randomizedParallel-groupOpen-labelHealth-services research

Summary

The aim of the study is to evaluate the pharmacokinetics of metformin in healthy Caucasians volunteers with and without the polymorphism A270S in OCT2,thus the study hypothesis is that renal clearance of metformin is affected in Caucasian with the known single nucleotide polymorphisms A270S in OCT2.

Timeline

Start
2010-08
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg —

Indications

No indication recorded.